1. Home
  2. IDCC vs TVTX Comparison

IDCC vs TVTX Comparison

Compare IDCC & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InterDigital Inc.

IDCC

InterDigital Inc.

SELL

Current Price

$325.80

Market Cap

6.6B

Sector

Miscellaneous

ML Signal

SELL

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

SELL

Current Price

$53.14

Market Cap

5.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
IDCC
TVTX
Founded
1972
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
5.3B
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
IDCC
TVTX
Price
$325.80
$53.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
15
Target Price
★ $462.67
$75.21
AVG Volume (30 Days)
166.1K
★ 1.6M
Earning Date
10-29-2026
10-29-2026
Dividend Yield
★ 0.84%
N/A
EPS Growth
N/A
★ 92.89
EPS
★ 5.51
N/A
Revenue
★ $307,404,000.00
N/A
Revenue This Year
N/A
$47.65
Revenue Next Year
N/A
$49.39
P/E Ratio
$60.41
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$249.14
$22.59
52 Week High
$412.60
$68.73

Technical Indicators

Market Signals
Indicator
IDCC
TVTX
Relative Strength Index (RSI) 45.79 33.14
Support Level $317.76 $41.75
Resistance Level $351.31 $59.93
Average True Range (ATR) 9.64 2.23
MACD -0.76 -0.59
Stochastic Oscillator 17.94 16.30

Price Performance

Historical Comparison
IDCC
TVTX

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, Video, Artificial Intelligence, and related Technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically, it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, with the majority is from China.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: